Cytokinetics, Incorporated CYTK
Set alert
63.07 USD +1.04 +1.68%
As of Nov 3, 2:42 PM ET
62.05 Day range 64.37
58.05 52-week range 88.31
- YTD
- -0.73%
- 1 year
- +5.07%
- Open
- 62.74
- Prev close
- 62.03
- Mkt cap
- 8.78B
- Vol
- 874.29K
- Avg vol
- 1.90M
- EPS
- -7.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 62.05
- High
- 64.37
- Forward P/E
- -14.09
- Beta
- 0.47
- Short ratio
- 8.18
- Inst. own
- 126.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 67.50
- 200-d avg
- 70.08
- 1y target
- 107.39
6M chart
Events in this range
- May 5, 2026Earnings: -1.67; estimate -1.67; surprise 0%
- Aug 6, 2026Earnings: -1.5; estimate -1.63; surprise 7.98%
- Aug 13, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 13, 2026Rating: Barclays · Overweight → Overweight
- Aug 31, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 16, 2026Rating: William Blair · — → Outperform
- Oct 19, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (26)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 13, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
Newest 20 of 26.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 107.39 +70.3% upside
Now 63.07
- Target (low)
- 81.00
- Target (mean)
- 107.39
- Target (high)
- 140.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
- Strong buy7
- Buy13
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.41 | -1.65 – -1.10 | -1.54 | +8.8% | 41.60M | +2048.8% | 18 |
| Next quarter | -1.39 | -1.76 – -1.02 | -1.50 | +7.4% | 62.59M | +252.5% | 18 |
| Current year | -5.88 | -6.38 – -4.75 | -6.54 | +10.2% | 158.49M | +80.0% | 18 |
| Next year | -4.40 | -5.90 – -3.14 | -5.88 | +25.1% | 430.63M | +171.7% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 31, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 13, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 7, 2026 | Needham | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 29, 2026 | UBS | Upgrade | Neutral | Buy |
| Jun 24, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 17, 2026 | Needham | Reiterated | Buy | Buy |
| May 19, 2026 | Citigroup | Initiated | — | Buy |
| May 12, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 6, 2026 | Stifel | Maintained | Buy | Buy |
| May 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 5, 2026 | Needham | Maintained | Buy | Buy |
| Apr 10, 2026 | Wells Fargo | Initiated | — | Overweight |
| Apr 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 18, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 17, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 26, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |